NTRK gene fusions can drive unregulated cell growth and proliferation in a range of cancer types. Recently, this pathway gained significant focus and attention in precision oncology.
Next-Generation Sequencing provides the most comprehensive view across a large number of genes and can identify NTRK gene fusions as well as other relevant alterations, with minimal sample tissue needed.
PD Dr. med. Spasenija Savic Prince
Institute for Medical Genetics and Pathology, University Hospital Basel, Switzerland
We offer several NGS-based, multi-biomarker assays for clinical research designed to simultaneously detect gene fusions, such as NTRK1, NTRK2 and NTRK3, as well as hundreds of DNA and RNA-based genomic alterations associated with cancer. They include: Oncomine Comprehensive Assay, Oncomine Focus Assay, and the Oncomine Childhood Cancer Research Assay.
Explore All Oncomine NGS Solutions
For Research Use Only. Not for use in diagnostic procedures.